Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Analog 23 is a promising compound for prostate cancer treatment.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Melatonin helps hair grow by activating a specific signaling pathway.

Substance P may contribute to hair loss by increasing oxidative stress and mitochondrial activity in hair follicles.

Drug repurposing shows promise for treating many medical conditions.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Taking tamsulosin or finasteride and being older increase the risk of floppy iris during cataract surgery.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Prolactin and TGF-β receptor blockers might help treat hair loss.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.